MENU
WDNA
ETF ticker: BATS
PRICE
CHANGE
NET ASSETS

WDNA stock forecast, quote, news & analysis

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”)... Show more

Category: #Health
WDNA
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for WDNA with price predictions
Jun 11, 2026

WDNA's Indicator enters downward trend

The Aroon Indicator for WDNA entered a downward trend on May 27, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 181 similar instances where the Aroon Indicator formed such a pattern. In of the 181 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WDNA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where WDNA's RSI Indicator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on June 11, 2026. You may want to consider a long position or call options on WDNA as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for WDNA just turned positive on June 11, 2026. Looking at past instances where WDNA's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

WDNA moved above its 50-day moving average on June 11, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for WDNA crossed bullishly above the 50-day moving average on June 03, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 20 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where WDNA advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

WDNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Regeneron Pharmaceuticals (NASDAQ:REGN), Archer Daniels Midland Company (NYSE:ADM).

Industry description

The investment seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (“index”). The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Market Cap

The average market capitalization across the WisdomTree BioRevolution ETF ETF is 49.2B. The market cap for tickers in the group ranges from 64.65K to 1.04T. LLY holds the highest valuation in this group at 1.04T. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the WisdomTree BioRevolution ETF ETF was -2%. For the same ETF, the average monthly price growth was 0%, and the average quarterly price growth was 7%. GPCR experienced the highest price growth at 11%, while ORGN experienced the biggest fall at -20%.

Volume

The average weekly volume growth across all stocks in the WisdomTree BioRevolution ETF ETF was -9%. For the same stocks of the ETF, the average monthly volume growth was -1% and the average quarterly volume growth was 5%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 62
Price Growth Rating: 51
SMR Rating: 80
Profit Risk Rating: 84
Seasonality Score: 33 (-100 ... +100)
View a ticker or compare two or three
WDNA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
WisdomTree Trust380 Madison AveNew York
Phone
866-909-9473
Web
www.wisdomtree.com
WDNA's Indicator enters downward trend